» Articles » PMID: 37766329

Implication of the Autophagy-Related Protein Beclin1 in the Regulation of EcoHIV Replication and Inflammatory Responses

Overview
Journal Viruses
Publisher MDPI
Specialty Microbiology
Date 2023 Sep 28
PMID 37766329
Authors
Affiliations
Soon will be listed here.
Abstract

The protein Beclin1 (BECN1, a mammalian homologue of ATG6 in yeast) plays an important role in the initiation and the normal process of autophagy in cells. Moreover, we and others have shown that Beclin1 plays an important role in viral replication and the innate immune signaling pathways. We previously used the cationic polymer polyethyleneimine (PEI) conjugated to mannose (Man) as a non-viral tool for the delivery of a small interfering (si) Beclin1-PEI-Man nanoplex, which specifically targets mannose receptor-expressing glia (microglia and astrocytes) in the brain when administered intranasally to conventional mice. To expand our previous reports, first we used C57BL/6J mice infected with EcoHIV and exposed them to combined antiretroviral therapy (cART). We show that EcoHIV enters the mouse brain, while intranasal delivery of the nanocomplex significantly reduces the secretion of HIV-induced inflammatory molecules and downregulates the expression of the transcription factor nuclear factor (NF)-kB. Since a spectrum of neurocognitive and motor problems can develop in people living with HIV (PLWH) despite suppressive antiretroviral therapy, we subsequently measured the role of Beclin1 in locomotor activities using EcoHIV-infected BECN1 knockout mice exposed to cART. Viral replication and cytokine secretion were reduced in the postmortem brains recovered from EcoHIV-infected mice when compared to EcoHIV-infected mice, although the impairment in locomotor activities based on muscle strength were comparable. This further highlights the importance of Beclin1 in the regulation of HIV replication and in viral-induced cytokine secretion but not in HIV-induced locomotor impairments. Moreover, the cause of HIV-induced locomotor impairments remains speculative, as we show that this may not be entirely due to viral load and/or HIV-induced inflammatory cytokines.

Citing Articles

Polymeric nanocarriers for therapeutic gene delivery.

Zhang J, Yang X, Chang Z, Zhu W, Ma Y, He H Asian J Pharm Sci. 2025; 20(1):101015.

PMID: 39931356 PMC: 11808530. DOI: 10.1016/j.ajps.2025.101015.

References
1.
Omeragic A, Kayode O, Hoque M, Bendayan R . Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders. Fluids Barriers CNS. 2020; 17(1):42. PMC: 7350632. DOI: 10.1186/s12987-020-00204-5. View

2.
Saylor D, Dickens A, Sacktor N, Haughey N, Slusher B, Pletnikov M . HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment. Nat Rev Neurol. 2016; 12(4):234-48. PMC: 4937456. DOI: 10.1038/nrneurol.2016.27. View

3.
Germinario R, Desantis T, Wainberg M . Insulin-like growth factor 1 and insulin inhibit HIV type 1 replication in cultured cells. AIDS Res Hum Retroviruses. 1995; 11(5):555-61. DOI: 10.1089/aid.1995.11.555. View

4.
Kaushik A, Jayant R, Nikkhah-Moshaie R, Bhardwaj V, Roy U, Huang Z . Magnetically guided central nervous system delivery and toxicity evaluation of magneto-electric nanocarriers. Sci Rep. 2016; 6:25309. PMC: 4855156. DOI: 10.1038/srep25309. View

5.
Soler Y, Rodriguez M, Austin D, Gineste C, Gelber C, El-Hage N . SERPIN-Derived Small Peptide (SP16) as a Potential Therapeutic Agent against HIV-Induced Inflammatory Molecules and Viral Replication in Cells of the Central Nervous System. Cells. 2023; 12(4). PMC: 9954444. DOI: 10.3390/cells12040632. View